Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for negative symptoms in early psychosis
2010-022463-35Phase 3Completed
- Sponsor
- Manchester Mental Health and Social Care NHS Trust
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia comparing Minocycline adjunctive treatment with Placebo adjunctive treatment (2 arms). Primary endpoints: Negative symptom severity at 12 months, Medial prefrontal grey matter volume and 2 more. Started May 2011; status: completed.
02
Drugs
minocycline
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2010-022463-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022463-35.